FGFR1 and central nervous system cancer: Oncogenic FGFR signaling has been found in 4% of pediatric brain tumors and up to 11% in pediatric low-grade glioma patients[39], and of all FGFR-altered pediatric gliomas, 42% contain internal tandem duplications in FGFR1[40].